TIS 0.00% 0.0¢ tissue therapies limited

Ann: Investor Presentation, page-5

  1. 409 Posts.
    lightbulb Created with Sketch. 18
    I like how they boast about an "over subscribed" response to the placement. This suggests that they have discounted too much and have therefore over-diluted existing holders. Comprehende ?
 
watchlist Created with Sketch. Add TIS (ASX) to my watchlist

Currently unlisted public company.

arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.